Quite recently, MGTX study revealed that thymectomy partly improved clinical outcomes in nonthymomatous MG patients [61], suggesting that, at least in some patients, the thymus probably is a resource of pathogenic nAChR Ab-producing B cells. Here, CHRNA4 is linked to myasthenia gravis.